22-49999318-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001371417.1(IL17REL):āc.790C>Gā(p.Arg264Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000856 in 1,612,990 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000072 ( 0 hom., cov: 31)
Exomes š: 0.000087 ( 0 hom. )
Consequence
IL17REL
NM_001371417.1 missense
NM_001371417.1 missense
Scores
3
5
11
Clinical Significance
Conservation
PhyloP100: 0.0590
Genes affected
IL17REL (HGNC:33808): (interleukin 17 receptor E like) Predicted to enable interleukin-17 receptor activity. Predicted to be involved in cytokine-mediated signaling pathway. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL17REL | NM_001371417.1 | c.790C>G | p.Arg264Gly | missense_variant | 9/15 | ENST00000695950.1 | NP_001358346.1 | |
IL17REL | NM_001371416.1 | c.790C>G | p.Arg264Gly | missense_variant | 9/15 | NP_001358345.1 | ||
IL17REL | NM_001001694.3 | c.574C>G | p.Arg192Gly | missense_variant | 9/15 | NP_001001694.2 | ||
IL17REL | XR_001755245.2 | n.909C>G | non_coding_transcript_exon_variant | 9/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL17REL | ENST00000695950.1 | c.790C>G | p.Arg264Gly | missense_variant | 9/15 | NM_001371417.1 | ENSP00000512282.1 | |||
IL17REL | ENST00000695951.1 | c.790C>G | p.Arg264Gly | missense_variant | 9/15 | ENSP00000512283.1 | ||||
IL17REL | ENST00000389983.7 | n.*709C>G | non_coding_transcript_exon_variant | 9/15 | 2 | ENSP00000374633.3 | ||||
IL17REL | ENST00000389983.7 | n.*709C>G | 3_prime_UTR_variant | 9/15 | 2 | ENSP00000374633.3 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152132Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
11
AN:
152132
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000108 AC: 27AN: 249816Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135610
GnomAD3 exomes
AF:
AC:
27
AN:
249816
Hom.:
AF XY:
AC XY:
15
AN XY:
135610
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000869 AC: 127AN: 1460740Hom.: 0 Cov.: 35 AF XY: 0.0000853 AC XY: 62AN XY: 726684
GnomAD4 exome
AF:
AC:
127
AN:
1460740
Hom.:
Cov.:
35
AF XY:
AC XY:
62
AN XY:
726684
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152250Hom.: 0 Cov.: 31 AF XY: 0.0000672 AC XY: 5AN XY: 74450
GnomAD4 genome
AF:
AC:
11
AN:
152250
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
18
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2023 | The c.574C>G (p.R192G) alteration is located in exon 9 (coding exon 6) of the IL17REL gene. This alteration results from a C to G substitution at nucleotide position 574, causing the arginine (R) at amino acid position 192 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;.
M_CAP
Benign
T
MetaRNN
Uncertain
D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MVP
MPC
0.92
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at